Claudine Bruck - Net Worth and Insider Trading

Claudine Bruck Net Worth

The estimated net worth of Claudine Bruck is at least $45,753 dollars as of 2024-11-13. Claudine Bruck is the Director of Annovis Bio Inc and owns about 6,067 shares of Annovis Bio Inc (ANVS) stock worth over $45,745. Claudine Bruck is also the Director of Navidea Biopharmaceuticals Inc and owns about 7,550 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $8. Details can be seen in Claudine Bruck's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Claudine Bruck has not made any transactions after 2021-10-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Claudine Bruck

To

Claudine Bruck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Claudine Bruck owns 2 companies in total, including Annovis Bio Inc (ANVS) , and Navidea Biopharmaceuticals Inc (NAVB) .

Click here to see the complete history of Claudine Bruck’s form 4 insider trades.

Insider Ownership Summary of Claudine Bruck

Ticker Comapny Transaction Date Type of Owner
ANVS Annovis Bio Inc 2021-10-11 director
NAVB Navidea Biopharmaceuticals Inc 2019-05-13 director

Claudine Bruck Latest Holdings Summary

Claudine Bruck currently owns a total of 2 stocks. Among these stocks, Claudine Bruck owns 6,067 shares of Annovis Bio Inc (ANVS) as of October 11, 2021, with a value of $45,745 and a weighting of 99.98%. Claudine Bruck also owns 7,550 shares of Navidea Biopharmaceuticals Inc (NAVB) as of May 13, 2019, with a value of $8 and a weighting of 0.02%.

Latest Holdings of Claudine Bruck

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANVS Annovis Bio Inc 2021-10-11 6,067 7.54 45,745
NAVB Navidea Biopharmaceuticals Inc 2019-05-13 7,550 0.00 8

Holding Weightings of Claudine Bruck


Claudine Bruck Form 4 Trading Tracker

According to the SEC Form 4 filings, Claudine Bruck has made a total of 2 transactions in Annovis Bio Inc (ANVS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Annovis Bio Inc is the acquisition of 181 shares on October 11, 2021, which cost Claudine Bruck around $5,006.

According to the SEC Form 4 filings, Claudine Bruck has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 2,550 shares on May 13, 2019, which cost Claudine Bruck around $4,845.

Insider Trading History of Claudine Bruck

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Claudine Bruck Trading Performance

GuruFocus tracks the stock performance after each of Claudine Bruck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Claudine Bruck is -49.88%. GuruFocus also compares Claudine Bruck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Claudine Bruck within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Claudine Bruck's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Claudine Bruck

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.75 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -17.5 LIMIT LIMIT LIMIT LIMIT LIMIT

Claudine Bruck Ownership Network

Ownership Network List of Claudine Bruck

No Data

Ownership Network Relation of Claudine Bruck

Insider Network Chart

Claudine Bruck Owned Company Details

What does Annovis Bio Inc do?

Who are the key executives at Annovis Bio Inc?

Claudine Bruck is the director of Annovis Bio Inc. Other key executives at Annovis Bio Inc include Chief Financial Officer Henry Iii Hagopian , director & President and CEO Maria-luisa Maccecchini , and Chief Financial Officer Jeffrey Brian Mcgroarty .

Annovis Bio Inc (ANVS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Annovis Bio Inc (ANVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Annovis Bio Inc (ANVS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Annovis Bio Inc (ANVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Annovis Bio Inc Insider Transactions

No Available Data

Claudine Bruck Mailing Address

Above is the net worth, insider trading, and ownership report for Claudine Bruck. You might contact Claudine Bruck via mailing address: 4995 Bradenton Ave, Suite 240, Dublin Oh 43017-3552.